PAION AG (GB:0NF3)
LSE:0NF3
Holding GB:0NF3?
Track your performance easily

PAION AG (0NF3) Income Statement

0 Followers

PAION AG Income Statement

Last quarter (Q2 2022), PAION AG's total revenue was €3.73M, an increase of 18656.49% from the same quarter last year. In Q2, PAION AG's net income was €-4.29M. See PAION AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
€ 20.28M€ 7.13M€ 19.66M€ 8.00M€ 2.77M€ 5.81M
Cost of Revenue
€ -16.36K€ 3.08M---€ 0.00
Gross Profit
€ 4.16M€ 4.05M€ 19.66M€ 8.00M€ 2.77M€ 5.81M
Operating Expense
€ 13.59M€ 26.07M€ 17.81M€ 17.33M€ 15.22M€ 21.68M
Operating Income
€ -9.44M€ -22.01M€ 1.84M€ -9.33M€ -12.46M€ -15.87M
Net Non Operating Interest Income Expense
€ -1.32M€ -502.72K€ -152.32K€ -122.42K€ 6.18K€ 20.00K
Other Income Expense
------
Pretax Income
€ -2.97M€ -22.58M€ 1.43M€ -9.45M€ -12.45M€ -15.85M
Tax Provision
€ -277.37K€ -795.89K€ -791.66K€ -2.43M€ -2.51M€ -3.76M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ -2.69M€ -21.79M€ 2.22M€ -7.02M€ -9.94M€ -12.09M
Basic EPS
€ -0.04€ -0.31€ 0.03€ -0.11€ -0.16€ -0.20
Diluted EPS
€ -0.04€ -0.31€ 0.03€ -0.11€ -0.16€ -0.20
Basic Average Shares
€ 271.81M€ 69.95M€ 66.89M€ 65.06M€ 63.63M€ 60.17M
Diluted Average Shares
€ 273.46M€ 70.16M€ 67.31M€ 65.18M€ 63.87M€ 60.62M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
€ 13.58M€ 29.14M€ 17.81M€ 17.33M€ 15.22M€ 21.68M
Net Income From Continuing And Discontinued Operation
€ -2.69M€ -21.79M€ 2.22M€ -7.02M€ -9.94M€ -12.09M
Normalized Income
€ -2.69M€ -21.79M€ 2.22M€ -7.02M€ -9.94M€ -12.09M
Interest Expense
€ 1.32M€ 2.07M€ 162.92K€ 123.39K--
EBIT
€ -9.87M€ -20.52M€ 1.59M€ -9.32M€ -12.46M€ -15.87M
EBITDA
€ -9.87M€ -18.82M€ 1.94M€ -9.21M€ -12.20M€ -15.52M
Currency in EUR

PAION AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis